Lymphadenopathy resident survival guide: Difference between revisions
Line 32: | Line 32: | ||
* For more detailed information in the causes of lymphadenopathy, [[Lymphadenopathy causes|click here]]. | * For more detailed information in the causes of lymphadenopathy, [[Lymphadenopathy causes|click here]]. | ||
== | ==Management== | ||
The algorathmn illustrates the approach to management of [[lymphadenopathy]]<ref name="pmid22750769">{{cite journal |vauthors=Garg PK, Jain BK, Dubey IB, Sharma AK |title=Generalized lymphadenopathy: physical examination revisited |journal=Ann Saudi Med |volume=33 |issue=3 |pages=298–300 |date=2013 |pmid=22750769 |pmc=6078537 |doi=10.5144/0256-4947.2012.01.7.1525 |url=}}</ref><ref name="pmid10549745">{{cite journal |vauthors=Soldes OS, Younger JG, Hirschl RB |title=Predictors of malignancy in childhood peripheral lymphadenopathy |journal=J. Pediatr. Surg. |volume=34 |issue=10 |pages=1447–52 |date=October 1999 |pmid=10549745 |doi=10.1016/s0022-3468(99)90101-x |url=}}</ref><ref name="pmid10189390">{{cite journal |vauthors=Ghirardelli ML, Jemos V, Gobbi PG |title=Diagnostic approach to lymph node enlargement |journal=Haematologica |volume=84 |issue=3 |pages=242–7 |date=March 1999 |pmid=10189390 |doi= |url=}}</ref><ref name="pmid28348622">{{cite journal |vauthors=Ramadas AA, Jose R, Varma B, Chandy ML |title=Cervical lymphadenopathy: Unwinding the hidden truth |journal=Dent Res J (Isfahan) |volume=14 |issue=1 |pages=73–78 |date=2017 |pmid=28348622 |pmc=5356393 |doi=10.4103/1735-3327.201136 |url=}}</ref>. Borrowed from:<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |date=March 2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid9803196">{{cite journal |vauthors=Ferrer R |title=Lymphadenopathy: differential diagnosis and evaluation |journal=Am Fam Physician |volume=58 |issue=6 |pages=1313–20 |date=October 1998 |pmid=9803196 |doi= |url=}}</ref><ref name="pmid12484692">{{cite journal |vauthors=Bazemore AW, Smucker DR |title=Lymphadenopathy and malignancy |journal=Am Fam Physician |volume=66 |issue=11 |pages=2103–10 |date=December 2002 |pmid=12484692 |doi= |url=}}</ref> | |||
{{familytree/ | {{familytree/start |summary=Management of lymphadenopathy}} | ||
{{familytree | | | | A01 | | | A01= }} | {{familytree | | | | | | | | | | Z01 | | | | | | | |Z01='''History'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br><div style="float: left; text-align: left; width: 20em; padding:1em;"> | ||
{{familytree | | | | |!| | | | }} | :❑[[Patient]] [[age]] (specific demographic characteristics ([[age]]) of certain [[malignancy|malignancies]])<br> | ||
{{familytree | | | | B01 | | | B01= }} | :❑ Duration of [[lymphadenopathy]] (<2 weeks or >1 year without an increase in size has low malignant potential)<br> | ||
{{familytree | | |,|-|^|-|.| | }} | :❑ Past medical history of underlying disease, suggestive of [[immunodeficiency]], or recurrent [[infections]]<br> | ||
{{familytree | | C01 | | C02 | C01= | C02= }} | :❑ Sexual history suggestive of infection transmission<br> | ||
:❑ Family history of certain malignant disorders ([[breast cancer]], or [[melanoma]])<br> | |||
:❑ Exposure to communicable [[infectious disease]]s/ travel to high-risk areas<br> | |||
:❑ Environmental exposure such as [[ultraviolet radiation|UV]] (skin cancer risk)/ animals/ occupational exposure <br> | |||
:❑ Social history such as tobacco use, alcohol use (head and neck cancers risk)<br> | |||
:❑ Associated symptoms such as [[pain]], [[fever]], [[weight loss]], [[anorexia]], [[cough]], or recurrent [[UTI]]s}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | }} | |||
{{familytree | | | | | | | | | | M01 | | | | | | | M01='''[[Physical exam]]'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"><br>'''Appearance of the [[patient]]'''<br>[[Cachexia]] or surgical scar marks demonstrating previous malignancy treatment<br> | |||
❑ [[Vital signs]]<br> | |||
:❑ [[Temperature]]: High-grade / low-grade fever may demonstrate [[infection]]. <br> | |||
:❑ [[Heart rate]]: [[Tachycardia]] with regular pulse may demonstrate [[infection]]. <br> | |||
:❑ [[Respiratory rate]]: [[Tachypnea]] may demonstrate [[respiratory system]] involvement ([[infection]]\ [[metastasis]]).<br> | |||
:❑ [[Blood pressure]]: [[Chronic hypertension]] or [[hypotension]] (may indicate [[sepsis]] as a complication).<br> | |||
:❑ [[Oxygen saturation]]: may be low if the [[respiratory system]] is affected.<br> | |||
❑ HEENT<br> | |||
❑ [[Cardiovascular examination]]<br> | |||
❑ [[Respiratory examination]]<br> | |||
❑ [[Gastrointestinal system]] exam includes [[oral examination]], [[abdominal examination]], and [[digital rectal exam]]. <br> | |||
:❑ [[Splenomegaly]]) may demonstrate [[infectious mononucleosis|IM]], [[Hodgkin's lymphoma|hodgkin's]]/ [[non-Hodgkin's lymphoma]], and [[sarcoidosis]]<br> | |||
❑ [[Limb (anatomy)|Extremities]] exam<br> | |||
❑ Skin exam: Evaluate for the lesions that indicate [[malignancy]] such as [[melanoma]]/ potential inoculation sites for germ such as traumatic lesions.}} | |||
{{familytree | | | | | | | | | | |!| | | | | | |}} | |||
{{familytree | | | | | | | | | | N01 | | | | | | | N01='''Palpable [[lymph node]]'''<div style="float: left; text-align: left; width: 20em; padding:1em;"><div class="mw-collapsible mw-collapsed"><br> | |||
❑ Location: (Localized vs generalized)<br> | |||
:❑ For nodes involving several groups of nodes; suspect malignancy.<br> | |||
:❑ An enlarged node in a lymphatic rich region; suspect local disease.<br> | |||
:❑ Associated red streaking, suspect [[lymphangitis]].<br> | |||
:❑ Left [[supraclavicular lymph nodes|supraclavicular L.N]] ([[Virchow's nodes]]); suspect [[gastric carcinoma]]<br> | |||
:❑ Right [[supraclavicular lymph nodes|supraclavicular L.N]], suspect intra-thoracic carcinoma<br> | |||
❑ Dimensions <br> | |||
The aforementioned dimensions are abnormal for a palpable [[lymph node]] but do not lead to the suspicion of a [[neoplasm]]. | |||
:❑ [[Supraclavicular lymph nodes|supraclavicular]], [[iliac lymph nodes|iliac]], [[epitrochlear lymph nodes|epitrochlear]], and [[popliteal lymph nodes]] >0.5cm <br> | |||
:❑ [[Inguinal nodes]] > 1.5 cm <br> | |||
:❑ Other area [[lymph nodes]] >1 cm <br> | |||
❑ Tenderness or pain: <br> | |||
:❑ Suspect [[infection]]. <br> | |||
:❑ A [[neoplastic]] node may also demonstrate [[pain]] due to [[hemorrhage]] associated with central necrosis or a brisk growing tumor.<br> | |||
❑ Consistency <br> | |||
:❑ Hard on palpation; suspect [[chronic inflammation]]<br> | |||
:❑ consistent- acute inflammation<br> | |||
:❑ Stony-hard and painless nodes-metastatic cancer/ [[granuloma]] <br> | |||
:❑ Firm and rubbery nodes- lymphoma<br> | |||
:❑ Matted [[lymph nodes|L.N]] suspect [[mycobacterium]] / [[sarcoidosis]]/ [[lymphoma]] / [[metastatic carcinoma]])<br> | |||
❑ Mobility<br> | |||
:❑ Freely movable; suspect [[infections]] and [[collagen vascular disease]]<br> | |||
:❑ Fixed [[Lymph node|L.N]] to surrounding tissue; suspect [[malignancy]]}}. | |||
{{familytree | | | | | | | | | | |!| | | | | | | }} | |||
{{familytree | | | | | | | | | | U01 | | | | | | | U01='''Labs'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; width: 20em; padding:1em;"> | |||
❑ [[CBC]] with differential<br> | |||
❑ [[ESR]]<br> | |||
❑ [[CMP]]<br> | |||
❑ [[Peripheral smaer]]<br> | |||
❑ [[Liver function tests|LFTs]]<br> | |||
*''Labs may be required at a later stage pf diagnosis''}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | }} | |||
{{familytree | | | | | | | | | | |!| | | | | | | }} | |||
{{familytree | |,|-|-|-|v|-|-|-|-|+|-|-|-|-|.| | |}} | |||
{{familytree | Y01 | | Y02 | |,| Y03 |.| | Y04 | | | |Y01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Diagnostic of self-limiting or benign disease'''<br> | |||
[[Pharyngitis]], [[URTI]], [[conjunctivitis]], [[cat-scratch disease]], etc|Y02='''Suggests infection/ serious infection'''|Y03='''Unexplained'''|Y04='''Suggests malignancy'''}} | |||
{{familytree | |!| | | |!| | |!| |!| |!| | |!|}} | |||
{{familytree | K01 | | K02 | |!| K03 |!| | K04 | | K01=<div style="float: left; text-align: left; width: 20em; padding:1em;"> May require specific tests<div class="mw-collapsible mw-collapsed"><br> | |||
❑ Throat swab<br> | |||
❑ [[Sputum exam]]| K02=Perform specific tests<div style="float: left; text-align: left; width: 20em; padding:1em;"><div class="mw-collapsible mw-collapsed"><br> | |||
❑ [[Mononucleosis|IM]]: [[Mononucleosis laboratory findings|Heterophile Antibody]] and [[Mononucleosis laboratory findings|monospot test]] <br> | |||
❑ [[Syphilis]]: [[VDRL]], [[RPR]]<br> | |||
❑ [[HIV]]: [[HIV test#Antibody tests|HIV antibody test]] <br> | |||
❑ [[CMV]]: Anti CMV [[IgM]]<br> | |||
❑ [[Autoimmune disorders]]: [[ANA]], [[Rheumatoid factor]], etc<br> | |||
❑ [[Tuberculosis]]: [[PPD]]<br> | |||
❑ [[Cat scratch fever|Cat scratch disease]]: [[IgM]], [[IgG]]|K03=Risk factors for [[malignancy]]<br>Family history, [[age]], exposure, etc|K04=Perform specific tests}} | |||
{{familytree | |!| | | |!| | |!| |!| |!| | |!|}} | |||
{{familytree | |!| | |,|^|.| |!| |!| |!| | F01 |F01=Excisional biopsy}} | |||
{{familytree | |!| B01 | | B02 | |!| |!| |,|^|-|.|B01=Positive|B02=Negative}} | |||
{{familytree | |!| | |!| | | | | |!| |`| J01 | | J02 | |J01=Negative|J02=Positive}} | |||
{{familytree | |!| | |!| | | | | |!| | | | | | | |!| | | |}} | |||
{{familytree | K04 | | K05 | | | |!| | | | | | | K03 | |K04=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ '''Treat'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; padding:1em;">with [[antibiotics]] if required and/ or symptomatic treatment<br> | |||
❑ For an untreatable or disease with residual symptoms counsel the [[patient]]<br> | |||
❑ Follow up for advancing or persistent [[lymphadenopathy|LAD]]|K05=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Treat'''<div class="mw-collapsible mw-collapsed"><br> | |||
❑ [[Mononucleosis medical therapy|IM treatment]]<br> | |||
❑ [[Syphilis medical therapy|Syphilis treatment]]<br> | |||
❑ [[HIV medical therapy|HIV treatment]]<br> | |||
❑ [[Cytomegalovirus infection medical therapy|CMV treatment]]<br> | |||
❑ [[Autoimmunity#Treatments|Treatment of autoimmune disorders]]<br> | |||
❑ [[Tuberculosis medical therapy|Tuberculosis treatment]]<br> | |||
❑ [[Cat scratch fever medical therapy|cat scratch disease treatment]]|K01=Low risk|K02=High risk|K03=Staging}} | |||
{{familytree | | | | | | | | | | |!| | | | | | |!|!|}} | |||
{{familytree | | | | | | |,|-|-|-|^|-|-|.| | | |!|V01 |V01='''Treat'''<div class="mw-collapsible mw-collapsed"><div style="float: left; text-align: left; padding:1em;"><br>Surgical resection/ [[chemotherapy]]/ [[radiotherapy]]}} | |||
{{familytree | | | | | | A01 | | | | | A02 | | |!| | | |A01= Low risk<br> |A02=High risk}} | |||
{{familytree | | | | | | |!| | | | | | |!| | | |!| | | }} | |||
{{familytree | | | | | | |!| | | | | | B01 |-|-|'| | B01=<div style="float: left; text-align: left; line-height: 150% ">Specific tests/ [[biopsy]]}} | |||
{{familytree | | | | | | |!| | | | | | | | }} | |||
{{familytree | | |,|-|-|-|^|-|-|.| | | | | | | | L01=Treatment}} | |||
{{familytree | | C01 | | | | | | C02 | | | | | | | | |C01=Localized|C02=Generalized}} | |||
{{familytree | | |!| | | | | | | |!| | | | | | | | }} | |||
{{familytree | | D01 | | | | | | D02 | | | | | | | | | D01=Review history and clues suggesting malignancy|D02=Review history and clues suggesting malignancy}} | |||
{{familytree | | |!| | | | | | | |!| | | | | | | | }} | |||
{{familytree | | E01 | | | | | | E02 | | | | | | | |E01=Observe 3-4 weeks|E02=<div style="float: left; text-align: left; padding:1em;">Specific tests such as [[CXR]], [[ultrasound]], [[CT]], lab workup, [[biopsy]]<div class="mw-collapsible mw-collapsed"> | |||
The [[Ultrasound|US]] findings that help differentiate benign [[lympdadenopathy|lAD]] from [[malignant]] include:<br> | |||
❑ '''Benign''': An isoechoic oviod shaped lesion with variable borders. High long axis/short axis ratio(L/S) of >2. A hilum is present with blood flow. Pulsatility index id <1.5. <br> | |||
❑ '''Malignant''': A hypoechoic round lesion with sharp borders. Low L/S ratio of <2. Hilum is absent with peripheral blood flow distribution. }} | |||
{{familytree | | |!| | | | | | |,|-|^|-|-|.| | | | | }} | |||
{{familytree | |,|^|-|.| | | | F01 | | | F02 | | | | |F01=Undiagnostic|F02=Diagnostic}} | |||
{{familytree | |!| | |!| | | | |!| | | | |!| | | | |}} | |||
{{familytree | L01 | |L02| | |!| | | | |!| | | | | | |L01=Progress/persists|L02=Regress}} | |||
{{familytree |!| | | |!| | | | |!| | | | |!| | | | | |}} | |||
{{familytree |!| | | |G03 | | | G01 | | | G02 | | | | | | |G01=Biopsy|G02=Treatment|G03=No follow-up}} | |||
{{familytree |!| | | |!| | | |,|-|^|.| | | | | | | | | | |}} | |||
{{familytree |!| | | |!| | | H01 | | H02 | | | | | | | | | |H01=Positive|H02=Negative }} | |||
{{familytree |!| | | |!| | | |!| | | |!| | | | | | | | | |}} | |||
{{familytree |!| | | |!| | | I01 | | I02 | | | | | | | | | |I01=Staging|I02= Follow-up}} | |||
{{familytree |G01 | |!| | | | |!| | | | | | | | | | | |G01=Biopsy}} | |||
{{familytree |!| | | |!| | | J01 | | | | | | | | | | | | | |J01=Treatment}} | |||
{{familytree |)|-|-| Q01 | | | | | | | | | | | | | | | | | | Q01=Negative|}} | |||
{{familytree |!| | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree |`|-|-| X01 | | | | | | | | | | | | | | | | | | | | | |X01=Positive}} | |||
{{familytree | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | Y01 | | | | | | | | | | | | | | | | | Y01=Staging}} | |||
{{familytree | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | E01 | | | | | | | | | | | | | | | | | |E01=Treatment}} | |||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 14:16, 22 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Javaria Anwer M.D.[2]
Overview
Lymphadenopathy (LAD) is used to describe abnormal size, consistency, and the number of lymph nodes. Under normal conditions, lymph nodes may not be palpated. The lymph nodes maybe central or peripheral located deep in the subcutaneous tissue. Common causes of lymphadenopathy include infectious and non-infectious. A thorough physical exam is important to establish a differential diagnosis.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- Infectious mediastinal lymphadenopathy[1]
Common Causes
The American Academy of Family Physicians (AAFP) and many research articles utilize a pneumonic CHICAGO to include all causes of lymphadenopathy based on etiology.[2][3] The causes may also be remembered based on the location of lymph nodes.
- Cancers:
- Hypersensitivity :
- Serum sickness, immunization reactions, graft-vs-host disease, silicone allergy, and drug allergy (such as sulfonamides, allopurinol, carbamazepine, etc).
- Infections:
- Fungal, Protozoan, Rickettsial (Typhus), Helminthes.
- Bacterial: Tiberculosis, syphilis (primary and secondary), chancroid, staphylococcus or streptococcal skin infections.
- Viral: IM, CMV, HIV,lymphadenitis post vaccination, adenovirus, herpes zoster, and hepatitis (infectious), and melioidosis.
- Chlamydial (lymphogranuloma venereum), protozoan (toxoplasmosis), mycotic (histoplasmosis, coccidioidomycosis, helminthic (filariasis, and rickettsial (typhus).
- Connective tissue disorders:
- Atypical lymphoproliferative disorders :
- Granulomatous:
- Others:
- Rosai Dorfman disease, Kikuchi disease, pseudotumor of L.N, transformation of germinal centers, and vascular transformation of sinuses.
- For more detailed information in the causes of lymphadenopathy, click here.
Management
The algorathmn illustrates the approach to management of lymphadenopathy[4][5][6][7]. Borrowed from:[8][9][10]
.History
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Physical exam Appearance of the patient Cachexia or surgical scar marks demonstrating previous malignancy treatment
❑ HEENT
❑ Extremities exam | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Palpable lymph node ❑ Location: (Localized vs generalized)
❑ Dimensions
❑ Tenderness or pain:
❑ Consistency
❑ Mobility
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Labs ❑ CBC with differential
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic of self-limiting or benign disease Pharyngitis, URTI, conjunctivitis, cat-scratch disease, etc | Suggests infection/ serious infection | Unexplained | Suggests malignancy | ||||||||||||||||||||||||||||||||||||||||||||||||||
May require specific tests | Perform specific tests ❑ IM: Heterophile Antibody and monospot test | Risk factors for malignancy Family history, age, exposure, etc | Perform specific tests | ||||||||||||||||||||||||||||||||||||||||||||||||||
Excisional biopsy | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | Positive | ||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Treat with antibiotics if required and/ or symptomatic treatment ❑ For an untreatable or disease with residual symptoms counsel the patient | Staging | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Treat | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Low risk | High risk | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Specific tests/ biopsy | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Localized | Generalized | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Review history and clues suggesting malignancy | Review history and clues suggesting malignancy | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Observe 3-4 weeks | Specific tests such as CXR, ultrasound, CT, lab workup, biopsy The US findings that help differentiate benign lAD from malignant include: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Undiagnostic | Diagnostic | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Progress/persists | Regress | ||||||||||||||||||||||||||||||||||||||||||||||||||||
No follow-up | Biopsy | Treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Staging | Follow-up | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Biopsy | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Positive | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Staging | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of [[disease name]] according the the [...] guidelines.
Do's
- Patients with immunodeficiency should have a wide differential diagnosis considering non-Hodgkin's lymphoma and Kaposi sarcoma.[10]
- Remember that lymphadenopathy involving supraclavicular L.N poses the highest risk of malignancy (90% among patients >40 years of age) and 25% among < 40 years old. [11]
Don'ts
- Physical examination should never be missed as a finding may change the course of differential diagnosis. Missing the physical exam may lead to unnecessary investigations and delays.[4]
- Needle aspiration biopsy or excisional biopsy is the gold standard for the tissue diagnosis and evaluation for lymphadenopathy.[8]
References
- ↑ Hiraishi Y, Goto Y, Ohishi N, Nagase T (May 2013). "Infectious mediastinal lymphadenopathy after repeated transbronchial needle aspiration". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007998. PMC 3669807. PMID 23723103.
- ↑ "Tips From Other Journals - American Family Physician".
- ↑ Habermann TM, Steensma DP (July 2000). "Lymphadenopathy". Mayo Clin. Proc. 75 (7): 723–32. doi:10.4065/75.7.723. PMID 10907389.
- ↑ 4.0 4.1 Garg PK, Jain BK, Dubey IB, Sharma AK (2013). "Generalized lymphadenopathy: physical examination revisited". Ann Saudi Med. 33 (3): 298–300. doi:10.5144/0256-4947.2012.01.7.1525. PMC 6078537. PMID 22750769.
- ↑ Soldes OS, Younger JG, Hirschl RB (October 1999). "Predictors of malignancy in childhood peripheral lymphadenopathy". J. Pediatr. Surg. 34 (10): 1447–52. doi:10.1016/s0022-3468(99)90101-x. PMID 10549745.
- ↑ Ghirardelli ML, Jemos V, Gobbi PG (March 1999). "Diagnostic approach to lymph node enlargement". Haematologica. 84 (3): 242–7. PMID 10189390.
- ↑ Ramadas AA, Jose R, Varma B, Chandy ML (2017). "Cervical lymphadenopathy: Unwinding the hidden truth". Dent Res J (Isfahan). 14 (1): 73–78. doi:10.4103/1735-3327.201136. PMC 5356393. PMID 28348622.
- ↑ 8.0 8.1 Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Ferrer R (October 1998). "Lymphadenopathy: differential diagnosis and evaluation". Am Fam Physician. 58 (6): 1313–20. PMID 9803196.
- ↑ 10.0 10.1 Bazemore AW, Smucker DR (December 2002). "Lymphadenopathy and malignancy". Am Fam Physician. 66 (11): 2103–10. PMID 12484692.
- ↑ Fijten GH, Blijham GH (October 1988). "Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup". J Fam Pract. 27 (4): 373–6. doi:10.1080/09503158808416945. PMID 3049914.